Portal de Periódicos da CAPES

National Trends and Geographic Variation in Bilateral Internal Mammary Artery Use in the United States

2017; Elsevier BV; Volume: 104; Issue: 6 Linguagem: Inglês

10.1016/j.athoracsur.2017.08.055

1552-6259

Alexander Iribarne, Philip P. Goodney, Alyssa M. Flores, Joseph P. DeSimone, Anthony W. DiScipio, Andrea M. Austin, Jock N. McCullough,

Tracheal and airway disorders

Background The goal of this study was to characterize the adoption rate and regional variation in bilateral internal mammary artery (BIMA) use during coronary artery bypass grafting (CABG) in the United States. Methods Observational study of 100% sample of fee-for-service Medicare beneficiaries aged 65 years or older, continuously enrolled in Parts A and B from 2009 to 2014 (n = 162,860,439). Rates of beneficiaries receiving a BIMA versus single internal mammary artery (SIMA) during CABG are expressed per 1,000 beneficiaries and aggregated by Hospital Referral Region (HRR). An HRR is a validated unit for quantifying regional variation in health care. Results The absolute national rate of BIMA use declined during the study period from 0.21 claims per 1,000 beneficiaries in 2009 to 0.13 in 2014 ( p < 0.001). When indexed to overall CABG volume, no change was seen in the frequency of BIMA use over time ( p = 0.883). SIMA use ranged from 1.3 to 8.5 claims per 1,000 Medicare beneficiaries, whereas BIMA use ranged from 0 to 1.5 ( p < 0.001). A significant correlation was found between regional volume of SIMA use and likelihood of BIMA use (correlation coefficient 0.673, p < 0.001). Although both SIMA and BIMA use correlated with regional volume of diagnostic cardiac catheterization, the correlation was stronger for SIMA use (correlation coefficient 0.962 versus 0.682, p < 0.001). Conclusions Over the past 5 years, no growth was seen in BIMA use among Medicare beneficiaries, and the frequency of BIMA use during CABG remained low. There was significant regional variation in BIMA use, however, which demonstrates opportunity for continued growth of BIMA grafting.